Enveric Biosciences Archives

Psychedelics News

Enveric Biosciences

Breaking News

18 May 2023

Enveric Biosciences Receives Patent Notice of Allowance for Novel Prodrug of Psilocin

This morning, Enveric Biosciences announced receipt of a patent allowance for Enveric's new chemical entity (NCE) psilocin prodrug being developed for the treatment of anxiety disorder....

By Microdose NewsDesk

Finance

4 Apr 2023

Enveric Biosciences Reports Q4 and Year-End 2022 Results

Enveric Biosciences, Inc....

By Microdose NewsDesk

Industry

11 Jul 2022

In Psychedelic Investing, Long-Term Thinking Is Key

In the fast-growing field of psychedelic medicine, long-term investing is key....

By Microdose

Don’t Miss

16 May 2022

News You Might Have Missed: May 16th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

17 Feb 2022

Enveric Biosciences and University of Calgary Collaborate on a Groundbreaking Clinical Trial for EVM-101 in Cancer Related Distress

Clinical trial aim is to include the identification and characterization of the Cancer Related Distress symptoms most responsive to psychedelic-associated therapy...

By Microdose

Press Releases

19 Jan 2022

Enveric Biosciences CEO, Dr. Joseph Tucker, Provides 2021 Year in Review and 2022 Outlook in Letter to Shareholders

Enveric launched as a patient-centric biotechnology company, employing innovation and scientific leadership as core principles....

By Microdose

Finance

19 Nov 2021

A Look at Small Cap Psychedelic Firms: Part 3

Small cap firms offer interesting potential opportunities for investors, so to help you stay informed we’ve put together a list of some of the top small cap companies....

By Jason Najum

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result